The trial assessed the efficacy and safety of Reblozyl compared to epoetin alfa, an erythropoiesis-stimulating agent, in treating anaemia due to MDS. It included subjects who needed red blood cell ...
Purpose: The cost of darbepoetin alfa versus that of epoetin alfa in a hospital setting was studied. Methods: The study was an observational, retrospective review of the hospitalwide use of ...
The COMMANDS study (NCT03682536) - a phase 3 open-label, randomised trial to evaluate the efficacy and safety of Reblozyl versus epoetin alfa - demonstrated high statistical significance and ...
Reblozyl was found to be superior to standard ESA therapy with Amgen and Johnson & Johnson's Epogen/Procrit (epoetin alfa) at achieving those objectives, with almost 59% of patients on BMS' drug ...
Saeed Sadeghi, MD, discusses the findings on transfusion independence achieved with treatment for patients with low-risk ...
The company develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells, imports, and exports medical devices and laboratory instruments ...
72 hr Manufacturer Dornase alfa Pulmozyme (Genentech) 24 hr Prescribing information Epoetin alfa multidose Procrit (Ortho Biotech) 7 days Manufacturer Epoetin alfa single dose Procrit (Ortho ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results